Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
Authors
Keywords
γ-secretase, β-secretase, APP C-terminal fragments, C99, toxicity, clinical trials
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume -, Issue -, Pages 100489
Publisher
Elsevier BV
Online
2021-03-01
DOI
10.1016/j.jbc.2021.100489
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unraveling the complexity of γ-secretase
- (2020) Michael S. Wolfe SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Opposite changes in APP processing and human Aβ levels in rats carrying either a protective or a pathogenic APP mutation
- (2020) Marc D Tambini et al. eLife
- Contribution of the Presenilins in the cell biology, structure and function of γ-secretase
- (2020) Abril Escamilla-Ayala et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase
- (2020) Pengju Nie et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Mechanisms of neurodegeneration — Insights from familial Alzheimer’s disease
- (2020) Lucía Chávez-Gutiérrez et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The Transcription Factor EB Reduces the Intraneuronal Accumulation of the Beta-Secretase-Derived APP Fragment C99 in Cellular and Mouse AD Models
- (2020) Anaïs Bécot et al. Cells
- The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
- (2020) Sarah A. Kent et al. ACTA NEUROPATHOLOGICA
- The substrate repertoire of γ-secretase/presenilin
- (2020) Gökhan Güner et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer’s disease models and human brains
- (2020) Loan Vaillant-Beuchot et al. ACTA NEUROPATHOLOGICA
- The Alzheimer's disease‐associated C99 fragment of APP regulates cellular cholesterol trafficking
- (2020) Jorge Montesinos et al. EMBO JOURNAL
- Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer’s disease
- (2020) Lutgarde Serneels et al. Molecular Neurodegeneration
- Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer’s disease mutations but not by inhibition of BACE1
- (2020) Erik C. B. Johnson et al. Molecular Neurodegeneration
- γ-Secretase Modulatory Proteins: The Guiding Hand Behind the Running Scissors
- (2020) Eitan Wong et al. Frontiers in Aging Neuroscience
- A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
- (2019) Francesco Panza et al. Nature Reviews Neurology
- Presenilins and γ-Secretase in Membrane Proteostasis
- (2019) Naoto Oikawa et al. Cells
- The APMAP interactome reveals new modulators of APP processing and beta-amyloid production that are altered in Alzheimer’s disease
- (2019) Hermeto Gerber et al. Acta Neuropathologica Communications
- Major Clinical Trials Failed the Amyloid Hypothesis of Alzheimer's Disease
- (2019) Yan-Mei Huang et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Does intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein trigger early neurotoxicity in Alzheimer’s disease?
- (2019) I. Lauritzen et al. Current Alzheimer Research
- The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
- (2019) Pierre Dourlen et al. ACTA NEUROPATHOLOGICA
- Lysosomal dysfunction in Down syndrome is APP-dependent and mediated by APP-βCTF (C99)
- (2019) Jiang Ying et al. JOURNAL OF NEUROSCIENCE
- γ-Secretase and its modulators: Twenty years and beyond
- (2019) Weiming Xia NEUROSCIENCE LETTERS
- Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease
- (2019) David Henley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
- (2019) Michael F. Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Substrate recognition and processing by γ-secretase
- (2019) Michael S. Wolfe BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Tuning of glutamate, but not GABA, release by an intra-synaptic vesicles APP domain whose function can be modulated by β- or α-secretase cleavage
- (2019) Wen Yao et al. JOURNAL OF NEUROSCIENCE
- BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
- (2019) Nour M. Moussa‐Pacha et al. MEDICINAL RESEARCH REVIEWS
- Hat die Alzheimer-Forschung versagt?
- (2019) Christian Haass et al. NERVENARZT
- Facilitation of glutamate, but not GABA , release in Familial Alzheimer's APP mutant Knock‐in rats with increased β‐cleavage of APP
- (2019) Marc D. Tambini et al. AGING CELL
- Intramembrane proteolysis at a glance: from signalling to protein degradation
- (2019) Nathalie Kühnle et al. JOURNAL OF CELL SCIENCE
- The neuropathological diagnosis of Alzheimer’s disease
- (2019) Michael A. DeTure et al. Molecular Neurodegeneration
- C99 selectively accumulates in vulnerable neurons in Alzheimer's disease
- (2019) Maria V. Pulina et al. Alzheimers & Dementia
- Investigational BACE inhibitors for the treatment of Alzheimer’s disease
- (2019) Bruno P. Imbimbo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
- (2019) Alette M. Wessels et al. JAMA Neurology
- A small molecule transcription factor EB activator ameliorates beta‐amyloid precursor protein and Tau pathology in Alzheimer's disease models
- (2019) Ju‐Xian Song et al. AGING CELL
- A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ
- (2019) Dylan Kwart et al. NEURON
- Aging and Alzheimer's disease pathology
- (2019) Renpei Sengoku NEUROPATHOLOGY
- Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis
- (2019) Gregory Klein et al. Alzheimers Research & Therapy
- Targeting γ-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models
- (2019) Inger Lauritzen et al. Translational Neurodegeneration
- Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease
- (2018) P Hemachandra Reddy et al. HUMAN MOLECULAR GENETICS
- Intraneuronal accumulation of C99 contributes to synaptic alterations, apathy-like behavior, and spatial learning deficits in 3xTgAD and 2xTgAD mice
- (2018) Alexandre Bourgeois et al. NEUROBIOLOGY OF AGING
- ABBY
- (2018) Jeffrey L. Cummings et al. NEUROLOGY
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
- (2018) Siddhartha Mondragón-Rodríguez et al. Frontiers in Cellular Neuroscience
- Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures
- (2018) André M. Miranda et al. Nature Communications
- The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
- (2018) Holly M. Brothers et al. Frontiers in Aging Neuroscience
- The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
- (2018) Ulf Neumann et al. EMBO Molecular Medicine
- The Many Substrates of Presenilin/γ-Secretase
- (2018) Annakaisa Haapasalo et al. JOURNAL OF ALZHEIMERS DISEASE
- Evidence that the Amyloid-β Protein Precursor Intracellular Domain, AICD, Derives From β-Secretase-Generated C-Terminal Fragment
- (2018) Brice Flammang et al. JOURNAL OF ALZHEIMERS DISEASE
- βCTF-Correlated Burst of Hippocampal TNFα Occurs at a Very Early, Pre-Plaque Stage in the TgCRND8 Mouse Model of Alzheimer's Disease
- (2018) Chelsea Cavanagh et al. JOURNAL OF ALZHEIMERS DISEASE
- Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
- (2018) Maarten Timmers et al. Alzheimers Research & Therapy
- Altered γ-Secretase Processing of APP Disrupts Lysosome and Autophagosome Function in Monogenic Alzheimer’s Disease
- (2018) Christy O.Y. Hung et al. Cell Reports
- Amyloid precursor protein and endosomal–lysosomal dysfunction in Alzheimer’s disease: inseparable partners in a multifactorial disease
- (2017) Ralph A. Nixon FASEB JOURNAL
- Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor
- (2017) Renaud Bussiere et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Notch Signaling in Development, Tissue Homeostasis, and Disease
- (2017) Chris Siebel et al. PHYSIOLOGICAL REVIEWS
- Phosphorylated Presenilin 1 decreases β-amyloid by facilitating autophagosome–lysosome fusion
- (2017) Victor Bustos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bidirectional regulation of Aβ levels by Presenilin 1
- (2017) Victor Bustos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer’s disease
- (2017) Valentine Hamm et al. Science Advances
- Intraneuronal aggregation of the β-CTF fragment of APP (C99) induces Aβ-independent lysosomal-autophagic pathology
- (2016) Inger Lauritzen et al. ACTA NEUROPATHOLOGICA
- Molecular genetics of early-onset Alzheimer's disease revisited
- (2016) Rita Cacace et al. Alzheimers & Dementia
- Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases
- (2016) Mathieu Bourdenx et al. Autophagy
- Restricted Location of PSEN2/γ-Secretase Determines Substrate Specificity and Generates an Intracellular Aβ Pool
- (2016) Ragna Sannerud et al. CELL
- Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways
- (2016) Stephen P. Duggan et al. CELLULAR SIGNALLING
- Influence of Genetic Background on Apathy-Like Behavior in Triple Transgenic AD Mice
- (2016) R. Pardossi-Piquard et al. Current Alzheimer Research
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer’s Disease
- (2016) Gvido Cebers et al. JOURNAL OF ALZHEIMERS DISEASE
- Localization and Processing of the Amyloid-β Protein Precursor in Mitochondria-Associated Membranes
- (2016) Dolores Del Prete et al. JOURNAL OF ALZHEIMERS DISEASE
- Presenilin 1 and Presenilin 2 Target γ-Secretase Complexes to Distinct Cellular Compartments
- (2016) Xavier Meckler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis
- (2016) Robert J. Andrew et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid precursor protein–mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration
- (2016) Wei Xu et al. JOURNAL OF CLINICAL INVESTIGATION
- Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?
- (2016) Matthew G. Bursavich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nicastrin is required for amyloid precursor protein (APP) but not Notch processing, while anterior pharynx-defective 1 is dispensable for processing of both APP and Notch
- (2016) Chen Hu et al. JOURNAL OF NEUROCHEMISTRY
- Functional involvement of γ-secretase in signaling of the triggering receptor expressed on myeloid cells-2 (TREM2)
- (2016) Konstantin Glebov et al. Journal of Neuroinflammation
- Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein
- (2016) G Kaur et al. MOLECULAR PSYCHIATRY
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Network abnormalities and interneuron dysfunction in Alzheimer disease
- (2016) Jorge J. Palop et al. NATURE REVIEWS NEUROSCIENCE
- Partial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF
- (2016) Ying Jiang et al. NEUROBIOLOGY OF AGING
- Cognitive deficits in single App knock-in mouse models
- (2016) Akira Masuda et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase
- (2016) Linfeng Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors
- (2016) Andrea M. Zuhl et al. Nature Communications
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
- (2016) Veronika Logovinsky et al. Alzheimers Research & Therapy
- Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD
- (2016) Nuomin Li et al. Frontiers in Aging Neuroscience
- Alzheimer’s disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio
- (2016) Ting-Hai Xu et al. Cell Discovery
- Pharmacological Inhibition of BACE1 Impairs Synaptic Plasticity and Cognitive Functions
- (2015) Severin Filser et al. BIOLOGICAL PSYCHIATRY
- Qualitative changes in human γ-secretase underlie familial Alzheimer’s disease
- (2015) Maria Szaruga et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Neuronal-Targeted TFEB Accelerates Lysosomal Degradation of APP, Reducing A Generation and Amyloid Plaque Pathogenesis
- (2015) Q. Xiao et al. JOURNAL OF NEUROSCIENCE
- Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer’s disease
- (2015) S Kim et al. MOLECULAR PSYCHIATRY
- η-Secretase processing of APP inhibits neuronal activity in the hippocampus
- (2015) Michael Willem et al. NATURE
- The case for rejecting the amyloid cascade hypothesis
- (2015) Karl Herrup NATURE NEUROSCIENCE
- Presenilin-1 Knockin Mice Reveal Loss-of-Function Mechanism for Familial Alzheimer’s Disease
- (2015) Dan Xia et al. NEURON
- Presenilin 1 Maintains Lysosomal Ca2+ Homeostasis via TRPML1 by Regulating vATPase-Mediated Lysosome Acidification
- (2015) Ju-Hyun Lee et al. Cell Reports
- The adipocyte differentiation protein APMAP is an endogenous suppressor of Aβ production in the brain
- (2014) Sebastien Mosser et al. HUMAN MOLECULAR GENETICS
- Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
- (2014) Janice A. Maloney et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the β secretase BACE1 for Alzheimer's disease therapy
- (2014) Riqiang Yan et al. LANCET NEUROLOGY
- Three-dimensional structure of human γ-secretase
- (2014) Peilong Lu et al. NATURE
- Study on Aβ34 biology and detection in transgenic mice brains
- (2014) Céline Caillava et al. NEUROBIOLOGY OF AGING
- Allosteric regulation of -secretase activity by a phenylimidazole-type -secretase modulator
- (2014) K. Takeo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The FAM3 superfamily member ILEI ameliorates Alzheimer’s disease-like pathology by destabilizing the penultimate amyloid-β precursor
- (2014) Hiroshi Hasegawa et al. Nature Communications
- mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies
- (2013) Antonella Caccamo et al. AGING CELL
- A fast growing spectrum of biological functions of γ-secretase in development and disease
- (2013) Nathalie Jurisch-Yaksi et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
- (2013) Xinglong Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Alterations in hippocampal network oscillations and theta-gamma coupling arise before Aβ overproduction in a mouse model of Alzheimer's disease
- (2013) Romain Goutagny et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Interactome Analyses of Mature γ-Secretase Complexes Reveal Distinct Molecular Environments of Presenilin (PS) Paralogs and Preferential Binding of Signal Peptide Peptidase to PS2
- (2013) Amy Hye Won Jeon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Trans-Dominant Negative Effects of Pathogenic PSEN1 Mutations on -Secretase Activity and A Production
- (2013) E. A. Heilig et al. JOURNAL OF NEUROSCIENCE
- Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
- (2013) Mathias Jucker et al. NATURE
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease
- (2012) Marta Pera et al. ACTA NEUROPATHOLOGICA
- Safety and Tolerability of the γ-Secretase Inhibitor Avagacestat in a Phase 2 Study of Mild to Moderate Alzheimer Disease
- (2012) Vladimir Coric et al. ARCHIVES OF NEUROLOGY
- BMS-708,163 Targets Presenilin and Lacks Notch-Sparing Activity
- (2012) Christina J. Crump et al. BIOCHEMISTRY
- The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
- (2012) Lucía Chávez-Gutiérrez et al. EMBO JOURNAL
- Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons
- (2012) Peer-Hendrik Kuhn et al. EMBO JOURNAL
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Differential Effects between -Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice
- (2012) Y. Mitani et al. JOURNAL OF NEUROSCIENCE
- The -Secretase-Derived C-Terminal Fragment of APP, C99, But Not A , Is a Key Contributor to Early Intraneuronal Lesions in Triple-Transgenic Mouse Hippocampus
- (2012) I. Lauritzen et al. JOURNAL OF NEUROSCIENCE
- Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy
- (2012) Robert Nisticò et al. MOLECULAR NEUROBIOLOGY
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline
- (2012) Thorlakur Jonsson et al. NATURE
- Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified γ-Secretase Complexes
- (2012) Matthias Cacquevel et al. PLoS One
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increases Aβ generation
- (2011) Lujia Zhou et al. EMBO Molecular Medicine
- β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia
- (2011) Robert Tamayev et al. EMBO Molecular Medicine
- Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage
- (2011) Maria Manczak et al. HUMAN MOLECULAR GENETICS
- Regulated intramembrane proteolysis - lessons from amyloid precursor protein processing
- (2011) Stefan F. Lichtenthaler et al. JOURNAL OF NEUROCHEMISTRY
- Potent amyloidogenicity and pathogenicity of Aβ43
- (2011) Takashi Saito et al. NATURE NEUROSCIENCE
- Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Aβ42 immunisation in Alzheimer’s disease
- (2010) Delphine Boche et al. ACTA NEUROPATHOLOGICA
- Macroautophagy Is Not Directly Involved in the Metabolism of Amyloid Precursor Protein
- (2010) Barry Boland et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- A γ-secretase inhibitor decreases amyloid-β production in the central nervous system
- (2009) Randall J. Bateman et al. ANNALS OF NEUROLOGY
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled Trial
- (2009) Robert C. Green JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aminopeptidase A contributes to the N-terminal truncation of amyloid β-peptide
- (2009) Jean Sevalle et al. JOURNAL OF NEUROCHEMISTRY
- Analysis of the γ-secretase interactome and validation of its association with tetraspanin-enriched microdomains
- (2009) Tomoko Wakabayashi et al. NATURE CELL BIOLOGY
- Alzheimer's-related endosome dysfunction in Down syndrome is A -independent but requires APP and is reversed by BACE-1 inhibition
- (2009) Y. Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- -Secretase Heterogeneity in the Aph1 Subunit: Relevance for Alzheimer's Disease
- (2009) L. Serneels et al. SCIENCE
- A Gene Network Regulating Lysosomal Biogenesis and Function
- (2009) Marco Sardiello et al. SCIENCE
- Importance of Lack of Interest in Patients With Mild Cognitive Impairment
- (2008) Philippe H. Robert et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Phase 2 Safety Trial Targeting Amyloid β Production With a γ-Secretase Inhibitor in Alzheimer Disease
- (2008) Adam S. Fleisher et al. ARCHIVES OF NEUROLOGY
- Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease
- (2008) Nikolai D Belyaev et al. EMBO REPORTS
- Intramembrane Proteolysis by γ-Secretase
- (2008) Harald Steiner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Substrate-targeting γ-secretase modulators
- (2008) Thomas L. Kukar et al. NATURE
- Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/ -secretase expression
- (2008) S. S. Hebert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now